本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Janux Therapeutics, Inc.

23.15
-0.3700-1.57%
盘后23.180.0300+0.13%19:30 EDT
成交量:204.00万
成交额:4,723.07万
市值:13.70亿
市盈率:-16.95
高:23.52
开:23.35
低:22.90
收:23.52
数据加载中...
2024/10/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/22

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/22

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities